The Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease: (Englisch)
- Neue Suche nach: Brennan, A.
- Neue Suche nach: Akehurst, R.
- Neue Suche nach: Davis, S.
- Neue Suche nach: Sakai, H.
- Neue Suche nach: Abbott, V.
- Neue Suche nach: Brennan, A.
- Neue Suche nach: Akehurst, R.
- Neue Suche nach: Davis, S.
- Neue Suche nach: Sakai, H.
- Neue Suche nach: Abbott, V.
In:
VALUE IN HEALTH
;
10
, 1
;
32-41
;
2007
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:The Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease:
-
Beteiligte:Brennan, A. ( Autor:in ) / Akehurst, R. ( Autor:in ) / Davis, S. ( Autor:in ) / Sakai, H. ( Autor:in ) / Abbott, V. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 10, 1 ; 32-41
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2007
-
Format / Umfang:10 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 10, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Cardioverter Defibrillators in Primary Prevention of Sudden Cardiac Death: A Cost or an Investment?:Boriani, G. et al. | 2007
- 3
-
A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases:Peterson, A. M. / Nau, D. P. / Cramer, J. A. / Benner, J. / Gwadry-Sridhar, F. / Nichol, M. et al. | 2007
- 13
-
Cost-Benefit Analysis of Preventing Sudden Cardiac Deaths with an Implantable Cardioverter Defibrillator versus Amiodarone:Caro, J. J. / Ward, A. / Deniz, H. B. / O'Brien, J. A. / Ehreth, J. L. et al. | 2007
- 23
-
Cost-Effectiveness of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy:Moore, S. / Tumeh, J. / Wojtanowski, S. / Flowers, C. et al. | 2007
- 32
-
The Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease:Brennan, A. / Akehurst, R. / Davis, S. / Sakai, H. / Abbott, V. et al. | 2007
- 42
-
Cost-Effectiveness Analysis of a Quality-Controlled Mammography Screening Program from the Swiss Statutory Health-Care Perspective: Quantitative Assessment of the Most Influential Factors:Neeser, K. / Szucs, T. / Bulliard, J. L. / Bachmann, G. / Schramm, W. et al. | 2007
- 54
-
The Effect of Disease, Functional Status, and Relapses on the Utility of People with Multiple Sclerosis in the UK:Orme, M. / Kerrigan, J. / Tyas, D. / Russell, N. / Nixon, R. et al. | 2007
- 61
-
Economic Evaluation of Palliative Management versus Peritoneal Dialysis and Hemodialysis for End-Stage Renal Disease: Evidence for Coverage Decisions in Thailand:Teerawattananon, Y. / Mugford, M. / Tangcharoensathien, V. et al. | 2007
- 73
-
Using EQ-5D to Derive General Population-based Utilities for the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA):Koltowska-Haggstrom, M. / Jonsson, B. / Isacson, D. / Bingefors, K. et al. | 2007
- S2
-
Is It Time for Managed Care Organizations to Cover Weight Reduction?Fine, M. et al. | 2007
- S4
-
Predicting the Prevalence of Cardiometabolic Risk Factors When Clinical Data Are LimitedHollenbeak, C. S. / Spackman, D. E. / Ben-Joseph, R. H. / Okamoto, L. J. / Luce, B. R. / Schwartz, J. S. / Sullivan, S. D. et al. | 2007
- S12
-
Economic Burden and Risk of Cardiovascular Disease and Diabetes in Patients with Different Cardiometabolic Risk ProfilesCaro, J. J. / O Brien, J. A. / Hollenbeak, C. S. / Spackman, E. / Ben-Joseph, R. / Okamoto, L. J. / Paramore, L. C. et al. | 2007
- S21
-
Metabolic Syndrome and Employer Sponsored Medical Benefits: An Actuarial AnalysisFitch, K. / Pyenson, B. / Iwasaki, K. et al. | 2007
- S29
-
Assessment of Cardiometabolic Risk Factors in a National Primary Care Electronic Health Record DatabaseBrixner, D. / Said, Q. / Kirkness, C. / Oberg, B. / Ben-Joseph, R. / Oderda, G. et al. | 2007
- S37
-
Simple Demographic Model to Predict Multiple Cardiometabolic Risk Factors in Two Well-Known Observational CohortsScranton, R. E. / Bozeman, S. R. / Burton, T. M. / Hoaglin, D. C. / Sirko, S. / Hollenbeak, C. S. / Wilson, P. W. F. et al. | 2007
- S45
-
Age-Specific Impact of Obesity on Prevalence and Costs of Diabetes and DyslipidemiaFinkelstein, E. A. / Brown, D. S. / Trogdon, J. G. / Segel, J. E. / Ben-Joseph, R. H. et al. | 2007
- S52
-
Cardiovascular Risk Factor Clusters and Employment in the United StatesSullivan, P. W. / Ghushchyan, V. et al. | 2007
-
Foreword: Exploring Cardiometabolic Complications of Obesity and Related Risk Factors: Prevalence and Economic ConsequencesSullivan, S. D. et al. | 2007